ArticleMolecular diagnosis & therapy2015

Antitumoral activity of tyrosine kinase inhibitors in patients with non-small cell lung cancer harbouring rare epidermal growth factor receptor mutations.

Matthijs Oyaert et al.PubMed ↗Publisher ↗

No numbers read from the abstract.